ABOS - Acumen Pharmaceuticals, Inc. Stock Price, Fair Value and News

$2.77+0.07 (+2.59%)

Delayed as of 22 Oct 2024, 09:55 am ET

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

ABOS Price Action

Last 7 days

15.7%

Last 30 days

8.8%

Last 90 days

-23.2%

Trailing 12 Months

-21.4%

ABOS RSI Chart

ABOS Valuation

Market Cap

162.2M

Price/Earnings (Trailing)

-2.5

Price/Sales (Trailing)

15.37

Price/Free Cashflow

-2.92

ABOS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ABOS Fundamentals

ABOS Revenue

Revenue (TTM)

10.8M

ABOS Earnings

Earnings (TTM)

-64.9M

Earnings Growth (Yr)

-76.89%

Earnings Growth (Qtr)

-38.08%

ABOS Profitability

Return on Equity

-26.59%

Return on Assets

-22.45%

Free Cashflow Yield

-34.29%

ABOS Investor Care

Shares Dilution (1Y)

3.82%

Diluted EPS (TTM)

-1.11

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q4
2024	0	0
2023	6.6M	10.8M
2022	0	2.4M
2020	0	1.4M

Get all data in R, Python etc through our Historical Stock Data APIs

About Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

CEO	Mr. Daniel J. O'Connell M.B.A.
WEBSITE	https://acumenpharm.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	39

Acumen Pharmaceuticals, Inc. Frequently Asked Questions

What is the ticker symbol for Acumen Pharmaceuticals, Inc.? What does ABOS stand for in stocks?

ABOS is the stock ticker symbol of Acumen Pharmaceuticals, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Acumen Pharmaceuticals, Inc. (ABOS)?

As of Mon Oct 21 2024, market cap of Acumen Pharmaceuticals, Inc. is 162.22 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ABOS stock?

You can check ABOS's fair value in chart for subscribers.

Is Acumen Pharmaceuticals, Inc. a good stock to buy?

The fair value guage provides a quick view whether ABOS is over valued or under valued. Whether Acumen Pharmaceuticals, Inc. is cheap or expensive depends on the assumptions which impact Acumen Pharmaceuticals, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ABOS.

What is Acumen Pharmaceuticals, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Oct 21 2024, ABOS's PE ratio (Price to Earnings) is -2.5 and Price to Sales (PS) ratio is 15.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ABOS PE ratio will change depending on the future growth rate expectations of investors.